retatrutide type 2 diabetes phase 2 results a1c trial Effects of on body composition in people with diabetes: a substudy of a 2, double-blind, TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight

A macro-friendly meal delivery plan that prioritizes lean protein, fiber, and lower refined carbohydrate intake supports visceral fat loss more effectively than a generic calorie-restriction approach

When to worry: Differentiating between standard reflux and something more serious

[15] [37] [38] In August 2025, the Food and Drug Administration (FDA) expanded the indication for semaglutide (as Wegovy) to include the treatment of noncirrhotic metabolic-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults

(PubMed) Svensson M, Malm C, Tonkonogi M, Ekblom B, Sjodin B, Sahlin K

Nestoros J, Ban T, Lehmann H